NCT06831474View on ClinicalTrials.gov

Excretion of Rivaroxaban in Human Breast Milk

PHASE1RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

April 1, 2026

Study Completion Date

July 31, 2026

Conditions
PostpartumVTE ProphylaxisVTE (Venous Thromboembolism)RivaroxabanBreastfeedingBreast Milk Collection
Interventions
DRUG

Rivaroxaban 10 MG Oral Tablet

10mg rivaroxaban daily

DRUG

Rivaroxaban 20 MG Oral Tablet

20mg rivaroxaban daily

Trial Locations (1)

19107

RECRUITING

Thomas Jefferson University Hospital, Philadelphia

All Listed Sponsors
lead

Thomas Jefferson University

OTHER